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Risk Factors and Management Options for the Adult Failed
Ureteropelvic Junction Obstruction Repair in the Era
of Minimally Invasive and Robotic Approaches:
A Comprehensive Literature Review
Alexander K. Chow, MD,1 Bryan J. Rosenberg, BA,2 Edward M. Capoccia, MD,2 and Edward E. Cherullo, MD2

Abstract

Guidelines for the management of pyeloplasty failure remain elusive given the rarity of this condition and the
difficulty of integrating and analyzing reported outcomes given the varying definition of failures. In this article,
we aim to review the existing literature on risk factors that may influence the surgical outcomes of reconstructive pyeloplasty for ureteropelvic junction obstruction. Furthermore, we discuss management options and
review success outcomes of treatment options for patients with pyeloplasty failure.
Keywords: pyeloplasty failure, salvage pyeloplasty, ureteropelvic junction obstruction, ureteral reconstruction

Introduction

U

reteropelvic junction obstruction (UPJO) is a
condition that describes the failure of antegrade urine
flow from the renal pelvis into the ureter due to an extrinsic or
intrinsic obstruction. While this is most commonly the consequence of a congenital obstruction, it can clinically manifest at any time of life, and the diagnosis is often times not
apparent until adulthood.1 Initial symptoms present as intermittent abdominal or flank pain of the affected side in
association with nausea or emesis. More often than not, this
diagnosis is made incidentally on radiographic imaging in the
absence of symptoms.
Surgical intervention is seldom required if the patient remains asymptomatic and if the obstruction does not progress
to renal function deterioration. In such patients, close observation with serial renal scans is an appropriate management option. Patient adherence through the observation
period is key, as one third of patients who undergo surveillance will require surgery within 4 years.2
The pyeloplasty is the industry’s gold standard for treatment of UPJO when surgery is indicated. While there are
multiple techniques to perform a pyeloplasty, all techniques
share similar treatment goals: preservation of renal function,
alleviation of pain, removal of stones, and prevention of recurrent infections. The refinement of this procedure using
minimally invasive techniques has brought the modern success range from 90% to 100%.3–5
1
2

That being said, we have not reached perfection with our
surgical outcomes and the prevalence of pyeloplasty failure
can be as high as 10% in the hands of experienced surgeons.3–5 Pyeloplasty can fail due to surgical technical error
or due to ischemia of the urothelial anastomosis, which results in stricture formation, with most failures occurring in
the first 2 years after the surgery.6
A comprehensive review of pyeloplasty failures and its
management is lacking in the literature. In this article, we
query the existing literature on risk factors thought to be
associated with pyeloplasty failures as well as summarize
management options for those who have failed a prior pyeloplasty. A review of the literature was conducted by search
of the National Library of Medicine (PubMed) in the English
language using the search terminology ‘‘adult + pyeloplasty +
failure’’ from January 1980 to present. Additional references
were culled from the reference list of the included studies.
Potential Risk Factors for Pyeloplasty Failure

In the first section of our review, we present potential risk
factors associated with surgical failures in patients who have
undergone pyeloplasty. We identify several patient and surgical
factors that have been investigated in the medical literature as
predictors of pyeloplasty failure, including poor preoperative
split renal function (SRF), patient age, early urine leak, presence of renal stones, and abnormal renal histology. We will
now review each of these factors and reference supporting data.
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Preoperative SRF

Early studies investigating preoperative SRF in the pediatric population found inconclusive evidence of its relationship to pyeloplasty failures.7,8 In the adult population, nuclear
medicine testing suggests higher surgical success with pyeloplasty for preoperative SRF greater than 30%. Patients with
a preoperative SRF ‡30% had a 50% chance of improved
renal function after the surgery, compared with only 20%
improvement in patients with SRF <30%.9 In contrast, a large
retrospective study of 138 patients did not find preoperative
SRF to be an independent predictor of recoverable postoperative renal function based on postsurgical renal scan at 6
months following Anderson–Hynes dismembered pyeloplasty.10 In light of these conflicting findings, a comprehensive analysis of pyeloplasty failures is limited as both studies
omitted failure endpoints such as subjective resolution of
symptoms or a need for a repeat procedure(s), both of which
are pivotal endpoints in outcome measurement.9,10
Preoperative SRF was also investigated by Grimsby and
colleagues in a cohort of patients who had undergone robotic
pyeloplasty.11 This study is unique in that it provided an updated analysis of the procedure performed with modern robotic
technology, a platform that offers enhanced visualization and
instrument articulation for precision suturing. Unlike previous
studies, Grimsby and colleagues provided a more inclusive
definition of pyeloplasty success, which includes: (1) objective
improvement of renal function, (2) absence of symptoms, and
(3) absence of a repeat operation. Pyeloplasty failure was defined as the failure to fulfill one or more of the three criteria.
Included in this analysis was 116 patients who were treated
with a variety of robotic pyeloplasty techniques with an 8%
(eight patients) failure rate at 17 months of follow-up. The
authors found a dramatic reduction of success rate with SRF
>30%, having a 97% success rate, compared with SRF <30%,
which had a 58% success rate. In the lens of modern surgical
techniques and utilizing this ‘‘trifecta’’ outcome measurement,
there appears to be a profound advantage for renal units with
>30% SRF compared with those below <30%.
Conflicting evidence was seen once again in a more recent
review of 139 patients that found no difference in surgical
outcomes when using an SRF cutoff of 25%.12 This group
found an improvement in renal function for certain individuals
as well as progressive decline in others with SRF of <25%.12 In
other words, having a poor preoperative SRF may not influence the trajectory of postoperative renal function. This study
suggests that pyeloplasty should not be ruled out in patients
with poor SRF (<25%) given the prospect of renal function
preservation, and at times improvement of the afflicted kidney.
Another study suggested that the pyeloplasty should still
be seen as a viable option, even for patients with dismal renal
function (0%–10%) following a period of decompression.13
In a study of 12 patients with SRF of <10%, all had a doubling
of the renal function with decompression alone with a percutaneous nephrostomy tube (PNT) for 4 to 6 weeks. During
this time, there was a demonstrable regrowth of renal cortical
and medullary parenchyma on serial renal sonographic
evaluation.13 SRF further improved to 35% to 45% following
formal repair with a pyeloplasty. This study underlines the
importance of renal decompression to accurately evaluate
recoverable renal function, which in turn will help dictate
surgical management.
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In summary, there is conflicting evidence in the literature
on the association of preoperative SRF of the affected kidney
and pyeloplasty success. These studies are limited by their
retrospective nature and power due to low incidence of
pyeloplasty failures. Furthermore, a cross comparison in the
literature is difficult to perform due to the varying definitions
of success among the authors. We find established SRF cutoffs in studies to be set relatively high, with most studies at
30% in comparison to 15% to 20% established by expert
opinion to determine the need for nephrectomy vs reconstructive procedure.14
Patient age as predictor

There are limited data on the relationship of the patient’s age
at the time of pyeloplasty and pyeloplasty success, with most
existing studies evaluating this relationship strictly in the pediatric population. Singla and colleagues investigated the impact of age at the time of repair and pyeloplasty success rates in
the adult population.12 No significant difference was observed
in the change in SRF after the surgery when stratified by age
( p = 0.120). On univariate Cox analysis, older age was predictive of stability or improvement in SRF after the surgery
across the entire cohort (hazard ratio [HR] 1.013, p = 0.016),
whereas preoperative SRF was not (HR 1.007, p = 0.429).
Thus, the authors concluded that older age is not associated
with worse outcomes and older adults should not be excluded
from a pyeloplasty when surgery is indicated.12
Interestingly, a difference for pyeloplasty success was seen
at middle age by another study. In a review of 138 adult patients undergoing Anderson–Hynes dismembered pyeloplasty,
patients younger than 35 years were identified as having a
recoverable renal function when compared with patients older
than 35 years.10 This phenomenon will need to be validated in
the future, but it has limited impact on practice management.
In the adult population, elderly age does not appear to
impact the outcome of pyeloplasty, suggesting that this surgery should be offered to older patients if they qualify as a
surgical candidate.
Prior endopyelotomy

An endopyelotomy is a minimally invasive alternative to a
pyeloplasty with approachable success rates, but those who
fail will undoubtedly necessitate a pyeloplasty. Cautionary
counseling for those patients undergoing endopyelotomy is
of utmost importance as the literature suggests that those who
fail may fare worse if a pyeloplasty is pursued in the future. In
a study of 759 pyeloplasties, with a mean follow-up time of
15 months, a previous endopyelotomy significantly increased
the risk for pyeloplasty failure. Two year freedom from a
repeat procedure was seen in 81% vs 93% of patients with and
without previous endopyelotomy, respectively ( p = 0.001).15
Endopyelotomy not only has a lower success rate as initial
treatment but also, when failed, can significantly diminish the
success of salvage pyeloplasty.15 This significant reduction in
success rate confirms that the pyeloplasty should truly be the
gold standard as initial treatment when indicated.
Early urine leak

Early anastomotic urine leak as detected by surgical drain
output has also been looked at as a predictor of success. Lim
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and Walker’s experience of 127 pyeloplasties had a success
rate of 98%, but in the three failures, two (66%) had persistently high surgical drain output requiring prolonged drain
duration.16 Seo and coworkers found a pyeloplasty failure
rate of 12% (8/65) at a mean follow-up of 3 years.17 When
comparing the success to the failures, none of the following
metrics: age, body mass index, abdominal surgical history,
initial stricture length, grade of hydronephrosis, presence of
an obstructing vessel, operation time, or blood loss were
significantly associated with pyeloplasty failures. The only
significant variable related to pyeloplasty failure was having
a high amount of surgical drain output ( p = 0.024).
High drain output implies a urine leak from a suboptimal
anastomosis due to poor tissue integrity, technical failure, or
tissue ischemia when presented in the delayed manner. The
presence of a urinary leak can stimulate a caustic reaction at
the anastomosis leading to anastomotic stricture with potential for recurrent obstruction.18
Presence of stones

The data on the presence of nephrolithiasis and pyeloplasty
success stem from retrospective studies evaluating concomitant pyelolithotomy with laparoscopic pyeloplasty. In 2002,
Ramakumar and colleagues reviewed 20 laparoscopic pyeloplasties performed with concomitant pyelolithotomy and
stone extraction with a success of 90%, a success similar to
published reports of pyeloplasty without the presence of
stones.19 Success in this definition was defined by a negative
postoperative renal scan and radiographic resolution of hydronephrosis. Stone-free rate was 90% at 3 months after the
surgery and 80% at 12 months after the surgery. More recently, Kadihasanoglu and colleagues performed a cohort
comparison of 43 adults who underwent laparoscopic pyeloplasty with and without concomitant pyelolithotomy and
found a success of 92.9% and 93.3%, respectively, based on a
negative renal scan at 3 months following the surgery.20
Thus, it can be concluded that the presence of stones and
concomitant pyelolithotomy has limited impact on the success of pyeloplasty. However, residual stone burden and the
risk of postoperative stone formation should be considered as
a possible postoperative issue. Efforts should be made at the
time of pyeloplasty to thorough evaluation of each calices
with flexible nephroscopy to minimize the possibility of residual stones and the need for ancillary procedures.
Histological abnormality

The pathological assessment of the excised obstructing
segment of urothelium and renal biopsies may provide a clue
to the success of a pyeloplasty repair. Histological characteristics including a reduced number of glomerular apparatus,
glomerular hyalinization, cortical cysts, and interstitial inflammation have all been found to be related to cases of
severe obstructive uropathy secondary to UPJO.21 All these
histological alterations were found to be present in scarred
renal pelvis due to severe obstruction.21 Thus, it is unclear if
the presence of any or a combination of these histological
alterations implies an increased risk of failure of the renal unit
despite a technically successful pyeloplasty.
Patients with UPJO and differential function of less than
35% had significant histological changes associated with the
renal parenchyma itself. One study that performed renal bi-
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opsies at the time of pyeloplasty found abnormal histology
correlative to poor preoperative and postoperative SRF on
radionuclide renal scans.22 Abnormal biopsies were seen in
six patients, of which five had a preoperative differential
function of less than 33%. None of these kidneys had an
improvement in SRF on repeat scan despite a technically
successful procedure.22 These studies imply that pyeloplasty
failure may be a factor of an initial irreversible renal insult at
a histological level rather than due to persistent obstruction
after repair. These histological analyses suggest that chronic
obstruction impacts the histological architecture of the kidney itself, but whether it is a marker for pyeloplasty failure
has yet to be determined (see Table 1 for key summary points
of risk factors associated with pyeloplasty failures).
Management of Failed Pyeloplasty

Although at a low incidence, pyeloplasty failures unfortunately do occur, often in the first 2 years after the surgery.6
The decision on secondary intervention should be made
based on the definition of failure and with treatment goals in
mind. One must recognize the varying definition of failures,
which can be simplified to persistence of pain, persistent
sequelae of obstruction (infection, stones, or rarely hypertension), continued decline in SRF, or a combination of the
above. Failure defined solely by a persistent decline in SRF
may not require repeat intervention in the absence of medical
sequelae from the progressive failing renal unit. Patients who
fail primary pyeloplasty based on persistent symptoms or
with recurrent nephrolithiasis or infections can be offered a
variety of management options, including salvage pyeloplasty, secondary endopyelotomy, ureterocalicostomy (for
the selected few), and nephrectomy.
Salvage pyeloplasty

A repeat pyeloplasty is feasible, and published series have
shown promising results with minimal blood loss, minimal
complications, and durable success rates.23 Shapiro and colleagues, in 2009, utilized the success trifecta (radiographic

Table 1. Key Summary Points of Risk Factors
Associated with Pyeloplasty Failures
1. There is conflicting evidence in the literature on the
association of preoperative SRF and pyeloplasty success.
2. Potential risks associated with failure: SRF <30, a prior
endopyelotomy, early urine leak
Not associated with failure: patient age, presence of
stones, concomitant pyelolithotomy
3. Chronic adult UPJO impacts the histological architecture
of the kidney potentially contributing to functional failure
despite a technically successful pyeloplasty.
4. A robust evaluation of pyeloplasty failures is limited due
to the small retrospective nature of existing studies and
the inconsistent definition of success/failure.
5. A better understanding of pyeloplasty success can be
better evaluated by standardizing the definition of success
to include:
(1) Objective improvement of renal function
(2) Resolution of subjective symptoms
(3) The absence of repeat procedures
SRF = split renal function; UPJO = ureteropelvic junction obstruction.
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resolution of renal obstruction, absence of symptoms, and
stable renal function) to gauge the success of their salvage
pyeloplasty experience. The cohort consisted of nine patients
who failed a primary open pyeloplasty and underwent a
salvage pyeloplasty with a success rate of 89%. This study
provided durable (>5 years) evidence in support of salvage
laparoscopic pyeloplasty as an excellent option for those
who have failed a previous open pyeloplasty.23 The mean
operative time was 204 (80–264) minutes with acceptable estimated blood loss (EBL 105 mL). There were no intraoperative or 30-day postoperative complications.23
Contemporary reports on laparoscopic salvage pyeloplasty
consisting of larger cohorts provided a higher power of
analysis to support the success rate of salvage pyeloplasty. In
2017, Chiancone and coworkers reported the outcomes of
transperitoneal laparoscopic salvage pyeloplasty for 38
consecutive patients, most of which (36 patients) had failed
primary dismembered pyeloplasty, while 2 patients had
failed primary endopyelotomy.24 The group provided reassuring results that salvage pyeloplasty offered a high success rate of 97.4% defined as the satisfaction of two criteria:
absence of symptoms and radiographic resolution of hydronephrosis on postoperative imaging. The perioperative outcomes and success rate of salvage pyeloplasty were also
found to be comparable to those of primary pyeloplasty in
matched cohort comparisons.25,26 Ambani and colleagues
matched 10 laparoscopic salvage pyeloplasty patients in a 1:3
ratio to 26 patients who underwent a primary laparoscopic
pyeloplasty and found no difference in preoperative, intraoperative, or postoperative variables.25 Notably, the EBL,
length of hospital stay, and 30-day Clavian morbidity events
were all comparable. At a radiographic and clinical follow-up
of 24 months, there was no significant difference in need for
reintervention. The only difference noted was the length of
operative time. On average, salvage pyeloplasty took 247
minutes compared with primary pyeloplasty, which required
175 minutes of operative time ( p = 0.03). Similarly, Hammady and colleagues performed a match cohort comparison
of 32 salvage cases and found salvage pyeloplasties to have a
slightly lower but comparable success rate of 90.6% compared with 94.4% of primary pyeloplasty in the hands of the
same surgeons.26
Salvage pyeloplasty is equally effective for patients who
had failed endoscopic management. Sundaram and colleagues in 2003 published their experience of the laparoscopic salvage pyeloplasty on 36 patients with symptomatic
success in 89% and objective response in 94% of their cohort.
Symptomatic success, however, was defined by 50% reduction of pain. The combined success rate was 83%.27
Minimally invasive (laparoscopic and robotic) salvage
pyeloplasty provides a high success rate, ranging from 88%
to 97%.23–27 Our review found that perioperative outcomes of
salvage pyeloplasty are comparable to that of primary pyeloplasty. The only exception is the prolonged operative time,
which improves with experience.25,27 It is important to consider reserving salvage pyeloplasty to the hands of high volume minimally invasive surgeons to replicate these results.
Secondary endopyelotomy

In credit to the evolution of surgical instrumentation and
minimally invasive techniques, endopyelotomy has now be-
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come an acceptable surgical approach for the management of
UPJO as primary or salvage treatment in the case of persistent
obstruction. There are many described modalities of endoscopic treatment including cold cutting with a hooked-shape
knife, Holmium laser ablation, and balloon dilation.14 The
benefit of a salvage endopyelotomy compared with a salvage
pyeloplasty is its relative ease, minimally invasive nature,
and expedited recovery period. Endopyelotomy may also be
considered in patients who have failed multiple pyeloplasties
and are no longer accepting further reconstructive surgery.
Success rates for secondary endopyelotomy are slightly
lower than that of secondary pyeloplasty, ranging from 66%
to 87%.28–32 Secondary endopyelotomy has also been found
to be less durable compared with secondary pyeloplasty, as
failure tends to occur within a shorter period.33 One of the
first reliable endopyelotomy techniques used in the salvage
setting is the hooked knife. Jabbour and colleagues recruited
72 patients who failed a primary open pyeloplasty and performed an antegrade endopyelotomy with a monopolar
electrocautery hooked knife with a success rate of 87.5% (63/
72). Success was defined clinically and radiographically at a
long follow-up of 88.5 months.30 Other modalities of secondary endopyelotomy include endoscopic balloon dilation,
cold knife incision, and laser ablation, all presented as case
reports or small series with lower success rates of 70%.28,34
Balloon dilation as a salvage procedure has had the lowest
success rate, which may be due to its inability to produce a
full-depth ablation of the scar tissue.28
In its infancy, the efficacy of Holmium laser ablation for
failed UPJO repair was merely reported in small case series
that provided cautionary success rates.31 Di Grazia and Nicolosi reported the experience of six patients who failed
primary pyeloplasty and underwent retrograde Holmium laser endopyelotomy. Only four patients (66%) reached success at 3 months following the surgery. There was no
advantage for hospital stay as the patients remained hospitalized on an average of 2 days, although this may be reflective of the surgeon’s preferred postoperative pathway.31
In recent decades, endopyelotomy has been the most popular
secondary treatment for pyeloplasty failure for the advantages that we had previously described.35 It has been suggested that success rates may be improved with proper
selection of patients, particularly omitting patients with a
crossing vessel and those with high-grade obstruction. Proper
patient selection brings the success rate to 95%, which is
comparable to that of pyeloplasty.36–39 The success of salvage
endopyelotomy may also be enhanced with a ureteral stent
placement before endopyelotomy.40 Acher and coworkers
identified 15 patients who failed primary pyeloplasty, of which
11 patients had ureteral stents placed before endopyelotomy.
An incisional endopyelotomy was performed followed by 7F
stent placement for 6 weeks postoperatively. All patients had
repeat intravenous urograms and renograms at 3 months
postprocedurally. Three (20%) patients failed, all of whom
were not stented before endopyelotomy.
Comparison of salvage pyeloplasty vs
secondary endopyelotomy

No randomized prospective head-to-head comparisons of
salvage pyeloplasty and secondary endopyelotomy have been
completed. The most robust head-to-head comparisons are
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Salvage pyeloplasty
(laparoscopic)
Salvage pyeloplasty
(laparoscopic)
Salvage pyeloplasty
(laparoscopic)
Secondary endopyelotomy
(Hook electrocautery)
Secondary endopyelotomy
(Holmium laser)
Secondary endopyelotomy

Secondary endopyelotomy
(Holmium laser)
Secondary endopyelotomy

Chiancone et al.24

Acher et al.40

N/A

N/A

29 40.35 (10–135)
3
199 (123–315)
9

17
41

9

N/A

N/A

20
15

N/A

N/A

133 – 42

247

103 – 30

N/A

204 (80–264)

Operative
time (minutes)

6

72

32

10

38

116

9

n

EBL = estimated blood loss; IVP = excretory urography; N/A = not available.

Swearingen et al.35 Secondary endopyelotomy
Salvage pyeloplasty
Nephrectomy

Vannahme et al.33

Varkarakis et al.34

Di Grazia
and Nicolosi31
Park et al.28

Jabbour et al.30

Hammady et al.26

Secondary endopyelotomy
Salvage pyeloplasty

Salvage pyeloplasty
(robotic)

Grimsby et al.11

Ambani et al.25

Salvage pyeloplasty
(laparoscopic)

Salvage procedure

Shapiro et al.23

Study

3 (0–50)
83 (25–175)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

110 (25–175)

122.37 – 73.2

N/A

105

EBL (mL)

0.3 (0–2)
1.3 (1–2)

N/A

N/A

2.4

4.7 (3–10)

2.1

N/A

2.7 – 2.3

2.4

4.47 – 0.86

N/A

2.1

Convalescence
days (range)

Need for repeat intervention

Resolution of symptoms
Stable or improved renal function on renal scan
Patent ureteropelvic junction on IVP
Objective improvement on renal scan
Resolution of symptoms
No need for further intervention
Postoperative renal scan with T1/2 £ 10

Definition of success

Symptomatic improvement
Stable or improved renal function
Improved renal scan
15/15 (100%) Symptomatic improvement
Improved drainage
8/9 (88.9%) Symptomatic relief
Improved radiographic imaging
44%
Symptomatic success
87.5%
Resolution of obstruction
No need for further intervention
13/34 (38%)
No need for further intervention
3/3 (100%)

14/20 (70%)

29/32 (90.6%) Symptomatic relief
Radiological improvement
63/72 (87.5%) Resolution of pain and urinary tract infections
Prompt secretion of contrast on IVP
4/6 (66.6%) Radiographic resolution

10/10 (100%)

32/38 (84%)

108/116 (92%)

8/9 (89%)

Success

Table 2. Series of Salvage Pyeloplasty and Secondary Endopyelotomy Following Failed Pyeloplasty
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two large retrospective reviews with prospective collection of
data.33,35 Vannahme and colleagues looked at those who
failed either pyeloplasty or endopyelotomy and found undeniably better results favoring salvage pyeloplasty over
secondary endopyelotomy.33 Subjective success as defined
by resolution of symptoms was 87% vs 74% favoring secondary pyeloplasty. Notably, the difference in success was
more pronounced when incorporating objective measures of
success on renal scan (94% vs 74%) and a need for a repeat
procedure (96% vs 71%). Substantial difference in the two
therapies was seen when utilizing the success trifecta, which
was overall 87.5% for secondary pyeloplasty and 44% for
secondary endopyelotomy.33
Swearingen and colleagues also found a strong preference
for salvage pyeloplasty over secondary endopyelotomy.35 In
a review of 41 patients who failed initial pyeloplasty, success
rate for pyeloplasty used in the secondary and tertiary setting
was 100% compared with 38% for endopyelotomy. Limitation for this study is that failure was defined only as the need
for repeat procedure.
In head-to-head comparisons, secondary endopyelotomy
is technically simpler and is a significantly quicker operation than salvage pyeloplasty.35 Risk of postoperative complications also favored secondary endopyelotomy. Studies
indicate that complications associated with endopyelotomy
tend to be infectious in nature, whereas the leading complications with pyeloplasties included postoperative bleeding
and early anastomotic urine leak.35
In regard to cost-effectiveness, the cost of secondary
therapy can be extrapolated from the literature on primary
treatment of adult UPJO.41 In this analysis of the MarketScan database, both open and minimally invasive pyeloplasties were more costly than endopyelotomy (*$22,000 vs
$16,000).36 Despite this cost advantage, we feel that salvage
pyeloplasty should still be the gold standard given it superior
success rate. Furthermore, failure with secondary endopyelotomy would potentiate costs if failure is encountered
and a tertiary procedure is necessitated.
Interestingly, when fully informed and given the choice to
decide, most patients prefer endoscopic management for the
benefit of minimally invasive approach and low complication
rate.34 All the aforementioned factors must weighed in consideration to help determine the best approach for a patient
with failed UPJ repair.
Refer to Table 2 for a summary comparison of salvage
pyeloplasty vs secondary endopyelotomy.

Table 3. Key Summary Points on the Management
of Pyeloplasty Failures
1. A minimally invasive salvage pyeloplasty is the gold
standard treatment for recurrent UPJO given its high
success rate.
2. Secondary endopyelotomy is an acceptable alternative
therapy for treatment of recurrent UPJO, although with a
lower success rate than salvage pyeloplasty.
3. Ureterocalicostomy is a highly selective procedure
performed in the unique circumstance of multiple
reoperated field.
4. Nephrectomy is considered for renal units with
nonsalvageable function (GFR <15%).
GFR = glomerular filtration rate.
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Ureterocalicostomy

An ureterocalicostomy can be offered under unique circumstances. Initial porcine model demonstrated pure laparoscopic success for long upper ureteral strictures measuring
up to 2 cm.42 This is a feasible approach in patients who have
failed multiple (two or more) pyeloplasties, have insufficient
renal pelvis tissue for reconstruction, and have a dilated,
thinned out lower pole calix available for an uretercaliceal
anastamosis.43 Series of minimally invasive ureterocalicostomies showed 100% success rate at a mean of 30 months
of follow-up with no major complications.43–45
Nephrectomy

A laparoscopic total nephrectomy may be the definitive
procedure of choice for failed primary surgical therapy, particularly if a normal contralateral kidney is present based on
radiographic and nuclear studies. Indications include persistent
pain, urinary tract infection, stones, or rarely, causal hypertension secondary to urinary obstruction. Generally, SRF of
<15% is considered nonsalvageable in adults,14 although prior
mentioned studies may disagree and find renal decompression
with either an internalized stent or a PNT to salvage function.13
Nephrectomy may also be a wise choice in patients who have
failed multiple repairs, in which case reoperation may be extremely challenging (see Table 3 for key summary points on
the management of pyeloplasty failures).14
Summary

Management of failed pyeloplasty should be based on the
definition of failure with consideration of anatomical factors,
patient preference, and the surgeon experience and comfort
level. Salvage pyeloplasty portends the highest success rate
and should be the gold standard for secondary therapy if feasible. Secondary endopyelotomy can be an alternative approach for those patients who do not desire salvage
pyeloplasty. With careful selection of patients (omittance of
high-grade obstruction and presence of crossing vessel), secondary endopyelotomy success approaches salvage pyeloplasty. Finally, an ureterocalicostomy is a highly selective
procedure performed in the unique circumstance of multiple
reoperated field, whereas nephrectomy will be definitive
therapy for renal units with nonsalvageable function (glomerular filtration rate <15%) even after decompression.
A better understanding of pyeloplasty success can be better
evaluated by standardizing the definition of success to include objective improvement of renal function, resolution of
subjective symptoms, and the absence of repeat procedures.
Future initiatives should include multi-institutional efforts in
prospective analysis to evaluate this relationship.
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ailure after a procedure that boasts a >90% success
rate is one of the most frustrating situations faced by a
surgeon. As surgeons, we use failures as tools for learning
and methods to identify practices for improvement. For many
procedures, failures can often be traced to certain techniques
or patient conditions that tend to result in poorer outcome.
This is not so in pyeloplasty. With success rates reported
between 90% and 100% in modern robotic surgery series,
failure after pyleoplasty can be as frustrating to the surgeon as
it is to the patient. A failure after pyleoplasty often leads us
scratching our heads in confusion.
In the preceding review, Chow et al. studied failure after
pyleoplasty in a method to identify potential causes.1 They
reviewed data on five different potential factors that could
lead to failure after pyeloplasty, including (1) patient renal
function at the time of surgery, (2) age, (3) prior intervention
(endopyelotomy) and early urine leak, (4) presence of stone,
and (5) histologic abnormalities on renal biopsy. Only urine

F

leak after surgery or before (caused by endopyelotomy) and
histologic abnormalities seemed to contribute to failure.
These are rare situations and largely out of our control. Unless subclinical urinary leaks are the primary source of failures in patients without previous endopyelotomy, these
findings bring no solace to the surgeon or patient who otherwise underwent an uneventful pyeloplasty.
Not all failures are really failures. Patients may have poor
drainage, however, maintain function and be symptom free. In
those situations, no intervention and continued follow-up are
all that is necessary. However, when interventions are needed,
it appears that most pyeloplasty failures can be salvaged with
an endopyelotomy or redo pyeloplasty. A redo pyeloplasty
appears to have better outcomes with more durable result
compared with endo pyelotomy, but the majority of patients
would prefer the less invasive treatment before a redo surgery.
Although this review tries to put a light on the etiology of
pyeloplasty failures, it really highlights our failures. Our
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